Works matching DE "AMISULPRIDE"

Results: 361

Excitation/inhibition imbalance in schizophrenia: a meta-analysis of inhibitory and excitatory TMS-EMG paradigms.

Published in:

Schizophrenia, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41537-024-00476-y

By:

Lányi, Orsolya;
Koleszár, Boróka;
Schulze Wenning, Alexander;
Balogh, David;
Engh, Marie Anne;
Horváth, András Attila;
Fehérvari, Péter;
Hegyi, Péter;
Molnár, Zsolt;
Unoka, Zsolt;
Csukly, Gábor

Publication type:

Article

False-Positive Buprenorphine by CEDIA in Patients Prescribed Amisulpride or Sulpiride.

Published in:

Journal of Analytical Toxicology, 2013, v. 37, n. 4, p. 233, doi. 10.1093/jat/bkt016

By:

Birch, M.A.;
Couchman, L.;
Pietromartire, S.;
Karna, T.;
Paton, C.;
McAllister, R.;
Marsh, A.;
Flanagan, R.J.

Publication type:

Article

Partial agonists of dopamine receptors: theoretical principles of combining antipsychotics including partial agonists to treat schizophrenia.

Published in:

BJPsych Advances, 2023, v. 29, n. 2, p. 151, doi. 10.1192/bja.2022.66

By:

Cookson, John;
Pimm, Jonathan;
Brentnall, Andrew

Publication type:

Article

Hyperprolactinaemia and antipsychotics.

Published in:

BJPsych Advances, 2015, v. 21, n. 4, p. 240, doi. 10.1192/apt.bp.113.012088

By:

Nelson, James C.;
Bell, Patrick M.;
Guy, Stephen T.

Publication type:

Article

Effects of Dopamine D2/D3 Blockade on Human Sensory and Sensorimotor Gating in Initially Antipsychotic-Naive, First-Episode Schizophrenia Patients.

Published in:

Neuropsychopharmacology, 2014, v. 39, n. 13, p. 3000, doi. 10.1038/npp.2014.152

By:

Düring, Signe;
Glenthøj, Birte Y;
Andersen, Gitte Saltoft;
Oranje, Bob

Publication type:

Article

Influence of Aripiprazole, Risperidone, and Amisulpride on Sensory and Sensorimotor Gating in Healthy 'Low and High Gating' Humans and Relation to Psychometry.

Published in:

Neuropsychopharmacology, 2014, v. 39, n. 10, p. 2485, doi. 10.1038/npp.2014.102

By:

Csomor, Philipp A;
Preller, Katrin H;
Geyer, Mark A;
Studerus, Erich;
Huber, Theodor;
Vollenweider, Franz X

Publication type:

Article

Asenapine versus other atycipal antipsychotics for schizoaffective disorder Case study.

Published in:

2024

By:

Shaska, E.

Publication type:

Abstract

Prolactin level changes according to atypical antipsychotics use: a study based on Clinical Data Warehouse.

Published in:

2024

By:

Sohn, I.;
Jeong, J.-H.

Publication type:

Abstract

Changes in clozapine dose and concomitant medication - a 10-year comparative study.

Published in:

2024

By:

Popa, A. V.;
Petric, P.;
Teodorescu, A.;
Ifteni, P. I.

Publication type:

Abstract

Safety during polypharmacy: A post-hoc analysis examining the safety profile of cariprazine with other antipsychotics in the cross-titration phase.

Published in:

European Psychiatry, 2021, v. 64, p. S533, doi. 10.1192/j.eurpsy.2021.1424

By:

Vass, G.;
Barabássy, Á.;
Laszlovszky, I.;
Sebe, B.;
Dombi, Z. B.;
Szatmári, B.;
Németh, G.

Publication type:

Article

Combination treatment with second generation antipsychotics other than clozapine.

Published in:

European Psychiatry, 2021, v. 64, p. S31, doi. 10.1192/j.eurpsy.2021.108

By:

Schmidt-Kraepelin, C.

Publication type:

Article

Paliperidone palmitate versus other antipsychotics.

Published in:

European Psychiatry, 2016, v. 33, p. S674, doi. 10.1016/j.eurpsy.2016.01.2003

By:

Hervías Higueras, P.;
Maroto Martín, L.;
Raffo Moncloa, S.;
Leonor del Pozo, M.

Publication type:

Article

The Effectiveness and Safety of Amisulpride in Chinese Patients with Schizophrenia.

Published in:

European Psychiatry, 2015, v. 30, p. 229, doi. 10.1016/S0924-9338(15)30188-7

By:

Liang, Y.;
Yu, X.

Publication type:

Article

Efficacy of Different Antipsyhotics in Combination with ECT in Resistant Schizophrenia.

Published in:

European Psychiatry, 2015, v. 30, p. 1622, doi. 10.1016/S0924-9338(15)31252-9

By:

Ravanic, D.;
Draskovic, M.;
Dejanovic, S. Djukic;
Petrovic, D.;
Jovanovic, M.;
Janjic, V.;
Radmanovic, B.

Publication type:

Article

Do Antipsychotics Affect Insight in Psychosis Differentially? Data From the EUFEST Trial.

Published in:

European Psychiatry, 2015, v. 30, p. 239, doi. 10.1016/S0924-9338(15)30194-2

By:

Pijnenborg, G.;
Timmerman, M.E.;
Derks, E.M.;
Fleischhacker, W.;
Kahn, R.S.;
Aleman, A.

Publication type:

Article

1403 – Hyperprolactinemia and antipsychotic use in psychiatric patients.

Published in:

2013

By:

Carvalho, M.;
Góis, C.

Publication type:

Abstract

726 – Improvement of obsessive-compulsive symptoms in schizophrenia patients after switching from typical or atypical antipsychotics to amisulpride.

Published in:

2013

By:

Sirota, P.;
Hadi, E.

Publication type:

Abstract

710 – Risperidone-associated deep venous thrombosis: case report and review.

Published in:

2013

By:

Ouanes, S.;
Abdelghaffar, W.;
Rafrafi, R.;
Jomli, R.;
Melki, W.;
Nacef, F.;
El-Hechmi, Z.

Publication type:

Abstract

P-1124 - Neuroleptic Malignant Syndrome during amisulpride therapy - a case presentation

Published in:

2012

By:

Zaluska, M.;
Janota, B.;
Brykalski, J.;
Kszczotek, M.

Publication type:

Abstract

P-1099 - Antipsychotic-induced hyperprolactinaemia

Published in:

2012

By:

Mendes, J.C.;
Oliveira, S.;
Ferreira, S.

Publication type:

Abstract

Dual disorder: does expert clinical experience support the rationale for cariprazine use?

Published in:

European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 5, p. 2095

By:

MARTINEZ-RAGA, J.;
BAJOUCO, M.;
KENZIN, D.;
SAHLSTEN, J.;
DE BERARDIS, D.;
TZEFERAKOS, G.;
WAGNER, E.;
FRANÇA, G.;
JOHNSEN, J.;
RONCERO, C.;
GRUNZE, H.

Publication type:

Article

Effect of chronotype on course of treatment in patients with schizophrenia under long-acting injectable antipsychotic treatment: one-year community mental health center experience.

Published in:

European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 15, p. 7155

By:

KAYA, A. ERDOĞAN;
AKTÜRK, B. ERDOĞAN

Publication type:

Article

Photocatalytic Degradation of Pharmaceutical Amisulpride Using g-C 3 N 4 Catalyst and UV-A Irradiation.

Published in:

Catalysts (2073-4344), 2023, v. 13, n. 2, p. 226, doi. 10.3390/catal13020226

By:

Antonopoulou, Maria;
Papadaki, Maria;
Rapti, Ilaeira;
Konstantinou, Ioannis

Publication type:

Article

Enhanced L-β-Aminoisobutyric Acid Is Involved in the Pathophysiology of Effectiveness for Treatment-Resistant Schizophrenia and Adverse Reactions of Clozapine.

Published in:

Biomolecules (2218-273X), 2023, v. 13, n. 5, p. 862, doi. 10.3390/biom13050862

By:

Fukuyama, Kouji;
Motomura, Eishi;
Okada, Motohiro

Publication type:

Article

Case report: Amisulpride therapy induced reversible elevation of creatine kinase-MB and bradycardia in schizophrenia.

Published in:

2022

By:

Ze-Rui Hu;
Zhen-Zhen Yang;
Xu-Bo Wang;
Hong-Shuo Chu;
Chuan-Xin Liu

Publication type:

Case Study

Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia.

Published in:

Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.930457

By:

Huimei An;
Hongzhen Fan;
Yajun Yun;
Song Chen;
Siyuan Qi;
Botao Ma;
Jing Shi;
Zhiren Wang;
Fude Yang

Publication type:

Article

Serum Levels and in vitro CX3CL1 (Fractalkine), CXCL8, and IL-10 Synthesis in Phytohemaglutinin-Stimulated and Non-stimulated Peripheral Blood Mononuclear Cells in Subjects With Schizophrenia.

Published in:

Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.845136

By:

Arabska, Jaśmina;
WysokiŃski, Adam;
BrzeziŃska-Błaszczyk, Ewa;
Kozłowska, Elżbieta

Publication type:

Article

Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses.

Published in:

Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.834333

By:

Nielsen, Mette Ødegaard;
Kristensen, Tina Dam;
Borup Bojesen, Kirsten;
Glenthøj, Birte Y.;
Lemvigh, Cecilie K.;
Ebdrup, Bjørn H.

Publication type:

Article

DETERMINATION OF IMPURITIES OF RISPERIDONE API BY ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY (UPLC).

Published in:

Rasayan Journal of Chemistry, 2020, v. 13, n. 2, p. 940, doi. 10.31788/RJC.2020.1325632

By:

Magar, L. P.;
Zaware, B. H.;
Laheru, C. J.;
Singh, Dharmendra;
Takate, S. J.;
Gupta, M. K.

Publication type:

Article

A STRAIGHT FORWARD, FAST, SENSITIVE, EPI- HPLCMS/MS METHOD FOR THE SIMULTANEOUS ESTIMATION OF CLOZAPINE AND AMITRIPTYLINE IN HUMAN PLASMA.

Published in:

Rasayan Journal of Chemistry, 2020, v. 13, n. 1, p. 24, doi. 10.31788/RJC.2020.1315466

By:

A., Muni Krishnaiah;
Chandraiah, C. Rama;
Srinivas, M.;
Devanna, N.

Publication type:

Article

Treatment-Resistant Schizophrenia, Clozapine Resistance, Genetic Associations, and Implications for Precision Psychiatry: A Scoping Review.

Published in:

Genes, 2023, v. 14, n. 3, p. 689, doi. 10.3390/genes14030689

By:

Ying, Jiangbo;
Chew, Qian Hui;
McIntyre, Roger S.;
Sim, Kang

Publication type:

Article

The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia.

Published in:

Genes, 2022, v. 13, n. 8, p. 1312, doi. 10.3390/genes13081312

By:

Paderina, Diana Z.;
Boiko, Anastasiia S.;
Pozhidaev, Ivan V.;
Mednova, Irina A.;
Goncharova, Anastasia A.;
Bocharova, Anna V.;
Fedorenko, Olga Yu.;
Kornetova, Elena G.;
Semke, Arkadiy V.;
Bokhan, Nikolay A.;
Loonen, Anton J. M.;
Ivanova, Svetlana A.

Publication type:

Article

A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia.

Published in:

Expert Review of Clinical Pharmacology, 2023, v. 16, n. 11, p. 1085, doi. 10.1080/17512433.2023.2274538

By:

Wu, Jie;
Kwan, Angela TH;
Rhee, Taeho Greg;
Ho, Roger;
d'Andrea, Giacomo;
Martinotti, Giovanni;
Teopiz, Kayla M;
Ceban, Felicia;
McIntyre, Roger S

Publication type:

Article

Clozapine for treatment refractory catatonia in individuals with autism spectrum disorder: a retrospective chart review study.

Published in:

Expert Review of Clinical Pharmacology, 2023, v. 16, n. 9, p. 865, doi. 10.1080/17512433.2023.2243820

By:

Thom, Robyn P;
Wu, Michael;
Ravichandran, Caitlin;
McDougle, Christopher J

Publication type:

Article

Improving clozapine utilization will require continued advocacy, drug sponsor interest, and FDA support to address REMS issues.

Published in:

Expert Review of Clinical Pharmacology, 2023, v. 16, n. 3, p. 177, doi. 10.1080/17512433.2023.2183192

By:

Leung, Jonathan G;
Ehret, Megan;
Love, Raymond C;
Cotes, Robert O

Publication type:

Article

Real-world effectiveness of olanzapine and risperidone in the treatment of schizophrenia in Brazil over a 16-year follow-up period; findings and implications.

Published in:

Expert Review of Clinical Pharmacology, 2021, v. 14, n. 2, p. 269, doi. 10.1080/17512433.2021.1865799

By:

Barbosa, Wallace Breno;
Gomes, Rosângela Maria;
Godman, Brian;
Acurcio, Francisco de Assis;
Guerra Júnior, Augusto Afonso

Publication type:

Article

Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review.

Published in:

Expert Review of Clinical Pharmacology, 2020, v. 13, n. 8, p. 875, doi. 10.1080/17512433.2020.1787831

By:

de Filippis, Renato;
Soldevila-Matías, Pau;
De Fazio, Pasquale;
Guinart, Daniel;
Fuentes-Durá, Inmaculada;
Rubio, Jose M.;
Kane, John M.;
Schoretsanitis, Georgios

Publication type:

Article

A pharmacological profile of intravenous amisulpride for the treatment of postoperative nausea and vomiting.

Published in:

Expert Review of Clinical Pharmacology, 2020, v. 13, n. 4, p. 331, doi. 10.1080/17512433.2020.1750366

By:

Fox, Gabriel;
Kranke, Peter

Publication type:

Article

A comprehensive review of the clinical utility of and a combined analysis of the clozapine/norclozapine ratio in therapeutic drug monitoring for adult patients.

Published in:

Expert Review of Clinical Pharmacology, 2019, v. 12, n. 7, p. 603, doi. 10.1080/17512433.2019.1617695

By:

Schoretsanitis, Georgios;
Kane, John M.;
Ruan, Can-Jun;
Spina, Edoardo;
Hiemke, Christoph;
de Leon, Jose

Publication type:

Article

Persistent hiccups associated with switching from paliperidone to amisulpride.

Published in:

Psychiatry & Clinical Neurosciences, 2015, v. 69, n. 6, p. 383, doi. 10.1111/pcn.12239

By:

Cheng, Chih ‐ Ming;
Tsai, Shih ‐ Jen

Publication type:

Article

Amisulpride-associated acute onset of metabolic syndrome in a schizophrenia patient.

Published in:

Psychiatry & Clinical Neurosciences, 2013, v. 67, n. 2, p. 131, doi. 10.1111/pcn.12021

By:

Chang, Chi‐Kang;
Hung, Galen Chin‐Lun

Publication type:

Article

Hyperprolactinemia induced by low-dosage amisulpride in Korean psychiatric patients.

Published in:

Psychiatry & Clinical Neurosciences, 2012, v. 66, n. 1, p. 69, doi. 10.1111/j.1440-1819.2011.02296.x

By:

Lee, Bun‐Hee;
Kang, Seung‐Gul;
Kim, Tae‐Woo;
Lee, Heon‐Jeong;
Yoon, Ho‐Kyoung;
Park, Young‐Min

Publication type:

Article

Shared decision-making interventions in the choice of antipsychotic prescription in people living with psychosis (SHAPE): Protocol for a realist review.

Published in:

PLoS ONE, 2024, v. 19, n. 7, p. 1, doi. 10.1371/journal.pone.0304626

By:

Fitzgerald, Ita;
Sahm, Laura J.;
Howe, Jo;
Maidment, Ian;
Wallace, Emma;
Crowley, Erin K.

Publication type:

Article

Metabolic Syndrome in people treated with Antipsychotics (RISKMet): A multimethod study protocol investigating genetic, behavioural, and environmental risk factors.

Published in:

PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0298161

By:

de Girolamo, Giovanni;
La Cascia, Caterina;
Macchia, Paolo Emidio;
Nobile, Maria;
Calza, Stefano;
Camillo, Laura;
Mauri, Maddalena;
Pozzi, Marco;
Tripoli, Giada;
Vetrani, Claudia;
Caselani, Elisa;
Magno, Marta

Publication type:

Article

Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer's disease.

Published in:

PLoS ONE, 2023, v. 18, n. 10, p. 1, doi. 10.1371/journal.pone.0286278

By:

Boyanova, Sevda T.;
Lloyd-Morris, Ethlyn;
Corpe, Christopher;
Rahman, Khondaker Miraz;
Farag, Doaa B.;
Page, Lee K.;
Wang, Hao;
Fleckney, Alice L.;
Gatt, Ariana;
Troakes, Claire;
Vizcay-Barrena, Gema;
Fleck, Roland;
Reeves, Suzanne J.;
Thomas, Sarah A.

Publication type:

Article

Application of nickel-doped graphene nanotubes to modified GCE as a sensitive electrochemical sensor for the antipsychotic drug clozapine in spiked human blood serum samples.

Published in:

Journal of the Iranian Chemical Society, 2023, v. 20, n. 5, p. 1179, doi. 10.1007/s13738-023-02745-6

By:

Ghanbari, Mohammad Hossein;
Norouzi, Zahra;
Amiri, Anahid

Publication type:

Article

Study of the chromatographic behavior of selected antipsychotic drugs on RP-TLC based on quantitative structure–retention relationships.

Published in:

Journal of the Iranian Chemical Society, 2019, v. 16, n. 5, p. 1019, doi. 10.1007/s13738-018-01576-0

By:

Ciura, Krzesimir;
Rutecka, Anna;
Szewczyk, Adrian;
Kawczak, Piotr;
Bączek, Tomasz;
Nowakowska, Joanna

Publication type:

Article

Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol.

Published in:

Journal of Psychopharmacology, 2012, v. 26, n. 9, p. 1231, doi. 10.1177/0269881111421974

By:

den Boon, FS;
Body, S;
Hampson, CL;
Bradshaw, CM;
Szabadi, E;
de Bruin, N

Publication type:

Article

Amisulpride-induced acute akathisia in OCD: an example of dysfunctional dopamine–serotonin interactions?

Published in:

Journal of Psychopharmacology, 2012, v. 26, n. 6, p. 887, doi. 10.1177/0269881111405363

By:

Ersche, Karen D;
Cumming, Paul;
Craig, Kevin J;
Müller, Ulrich;
Fineberg, Naomi A;
Bullmore, Edward T;
Robbins, Trevor W

Publication type:

Article

Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis.

Published in:

Journal of Psychopharmacology, 2012, v. 26, n. 5, p. 42, doi. 10.1177/0269881112442016

By:

Cookson, John;
Hodgson, Richard;
Wildgust, Hiram J

Publication type:

Article